Bl 32 - analogs
| Prices in pharmacies: Instructions Bl 32 | |||||||||
|
ⓘ✘Enter drugs for checking interactions through a quick button search . Origanum majorana ✘ |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. | ||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
- 67% Bl 31 neutral
- 58% Bl 34 neutral
- 48% Bl 33 neutral
- 37% Du 3 neutral
- 30% Sp 7 neutral
- 30% Liv 9 neutral
- 30% Bl 26 neutral
- 28% Ren 2 neutral
- 27% Bl 28 neutral
- 27% Kid 13 neutral
- 26% Bl 55 neutral
- 26% Bl 54 neutral
- 25% Bl 52 neutral
- 25% Bl 27 neutral
- 25% Gb 26 neutral
- 25% Kid 8 neutral
- 24% Bl 30 neutral
- 23% Liv 6 neutral
- 23% Du 2 neutral
- 22% Kid 5 neutral
- 20% Bl 61 neutral
- 20% Si 6 neutral
- 20% Bl 53 neutral
- 20% PC70 Чжу-чжан neutral
- 19% St 31 neutral
- 19% Bl 24 neutral
- 18% Gb 36 neutral
- 18% Bl 37 neutral
- 18% Bl 39 neutral
- 18% Ren 1 neutral
- 18% Bl 38 neutral
- 17% Gb 32 neutral
- 17% Kid 15 neutral
- 17% Дань-нан-дянь neutral
- 17% Нэй-кунь-лунь neutral
- 16% Kid 14 neutral
- 16% St 32 neutral
- 16% Gb 25 neutral
- 16% Gb 27 neutral
- 16% Liv 11 neutral
- 16% St 38 neutral
- 16% Du 5 neutral
- 16% Du 6 neutral
- 15% Bl 67 neutral
- 15% L.i. 15 neutral
- 15% Ren 5 neutral
- 15% St 28 neutral
- 15% St 29 neutral
- 15% Bl 35 neutral
- 14% Kid 9 neutral
Learn more about the selection of analogues
▶
- The drug has «Bl 32» no complete analogues; 51 analog by action, the most similar - Bl 31 .
- Medical online service has selected the best substitutes for Bl 32 based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of analogues Bl 32 to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.